Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.

被引：0
|
作者：
Faustman, Denise L.
Torrey, Heather
Butterworth, John
Mera, Toshi
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Warden, Sara
Plager, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity
    Yang, Michael
    Tran, Lisa
    Torrey, Heather
    Song, Yaerin
    Perkins, Haley
    Case, Katherine
    Zheng, Hui
    Takahashi, Hiroyuki
    Kuhtreiber, Willem M.
    Faustman, Denise L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (06) : 971 - 980
  • [2] Antagonism of TNFR2: Focus on novel antibodies with preference for tumor microenvironment Tregs and oncogenes expressed on the tumor
    Khodadoust, Michael
    Kim, Youn
    Yang, Michael
    Torrey, Heather
    Tran, Lisa
    Faustman, Denise
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
    Takahashi, Hiroyuki
    Yoshimatsu, Gumpei
    Faustman, Denise Louise
    CELLS, 2022, 11 (12)
  • [4] Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies
    Torrey, Heather
    Butterworth, John
    Mera, Toshiyuki
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Defusco, Audrey
    Plager, Sara
    Warden, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise L.
    CANCER RESEARCH, 2017, 77
  • [5] Novel targeting of tumor-infiltrating TNFR2 Tregs: removing suppression with microenvironment-specific antibodies
    Torrey, Heather
    Butterworth, John
    Mera, Toshiyuki
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Defusco, Audrey
    Plager, Sara
    Warden, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise L.
    CANCER RESEARCH, 2017, 77
  • [6] Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sezary syndrome
    Torrey, H.
    Khodadoust, M.
    Tran, L.
    Baum, D.
    Defusco, A.
    Kim, Y. H.
    Faustman, D. L.
    LEUKEMIA, 2019, 33 (05) : 1206 - 1218
  • [7] Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
    Ali Mussa
    Nor Hayati Ismail
    Mahasin Hamid
    Mohammad A. I. Al-Hatamleh
    Anthony Bragoli
    Khalid Hajissa
    Noor Fatmawati Mokhtar
    Rohimah Mohamud
    Vuk Uskoković
    Rosline Hassan
    Journal of Experimental & Clinical Cancer Research, 43 (1)
  • [8] Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
    Torrey, Heather
    Butterworth, John
    Mera, Toshiyuki
    Okubo, Yoshiaki
    Wang, Limei
    Baum, Danielle
    Defusco, Audrey
    Plager, Sara
    Warden, Sarah
    Huang, Daniel
    Vanamee, Eva
    Foster, Rosemary
    Faustman, Denise L.
    SCIENCE SIGNALING, 2017, 10 (462)
  • [9] An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering
    Inoue, Masaki
    Tsuji, Yuta
    Kashiwada, Ayaka
    Yokoyama, Asahi
    Iwata, Akane
    Abe, Yasuhiro
    Kamada, Haruhiko
    Tsunoda, Shin-ichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 697
  • [10] Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
    H Torrey
    M Khodadoust
    L Tran
    D Baum
    A Defusco
    Y H Kim
    D L Faustman
    Leukemia, 2019, 33 : 1206 - 1218
12345